Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,321
datasets available to search
ShareScore release 0.9.0
Dataset results
1,321 results for “HIV-1”
Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults
ClinicalTrials.gov study NCT00389207. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection
ClinicalTrials.gov study NCT02073656. IPD Sharing: YES. Countries: 4. Publications: 3.
A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)
ClinicalTrials.gov study NCT05631093. IPD Sharing: YES. Countries: 8. Publications: 1.
Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels
ClinicalTrials.gov study NCT05458102. IPD Sharing: NO. Countries: 1. Publications: 1.
A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects
ClinicalTrials.gov study NCT00833781. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults
ClinicalTrials.gov study NCT02990325. IPD Sharing: NO. Countries: 1. Publications: 1.
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
ClinicalTrials.gov study NCT02415595. IPD Sharing: Not stated. Countries: 12. Publications: 1.
A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FT
ClinicalTrials.gov study NCT05630755. IPD Sharing: YES. Countries: 6. Publications: 1.
Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
ClinicalTrials.gov study NCT00869557. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection
ClinicalTrials.gov study NCT02175680. IPD Sharing: NO. Countries: 1. Publications: 1.
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
ClinicalTrials.gov study NCT00903682. IPD Sharing: Not stated. Countries: 11. Publications: 3.
Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)
ClinicalTrials.gov study NCT04223791. IPD Sharing: YES. Countries: 11. Publications: 1.
Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)
ClinicalTrials.gov study NCT04223778. IPD Sharing: YES. Countries: 15. Publications: 1.
A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines
ClinicalTrials.gov study NCT04586673. IPD Sharing: NO. Countries: 1. Publications: 1.
Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
ClinicalTrials.gov study NCT01818596. IPD Sharing: YES. Countries: 9. Publications: 2.
Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants
ClinicalTrials.gov study NCT03934541. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Anti
ClinicalTrials.gov study NCT01854775. IPD Sharing: YES. Countries: 5. Publications: 4.
Enhancement by Poly-ICLC During HIV-1 Infection
ClinicalTrials.gov study NCT02071095. IPD Sharing: Not stated. Countries: 1. Publications: 46.
Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants
ClinicalTrials.gov study NCT04607408. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
ClinicalTrials.gov study NCT02256631. IPD Sharing: Not stated. Countries: 4. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.